Cargando…
Depleting TMED3 alleviates the development of endometrial carcinoma
BACKGROUND: As one of gynecologic tumors, endometrial carcinoma (EC) has been characterized by high incidence rate, but its molecular pathogenesis has remained unclear. TMED3 is a membrane protein and has been indicated to implicate several tumor-related diseases. In the current study, we aimed to e...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295347/ https://www.ncbi.nlm.nih.gov/pubmed/35854294 http://dx.doi.org/10.1186/s12935-022-02649-0 |